107 related articles for article (PubMed ID: 29468983)
1. Synthesis and DFT Study on Hantzsch Reaction to Produce Asymmetrical Compounds of 1,4-Dihydropyridine Derivatives for P-Glycoprotein Inhibition as Anticancer Agent.
Mollazadeh S; Moosavi F; Hadizadeh F; Seifi M; Behravan J; Iman M
Recent Pat Anticancer Drug Discov; 2018; 13(2):255-264. PubMed ID: 29468983
[TBL] [Abstract][Full Text] [Related]
2. Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent.
Mollazadeh S; Shamsara J; Iman M; Hadizadeh F
Recent Pat Anticancer Drug Discov; 2017; 12(2):174-185. PubMed ID: 28137213
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
4. Theoretical studies on 1,4-dihydropyridine derivatives as P-glycoprotein allosteric inhibitors: insights on symmetry and stereochemistry.
Mollazadeh S; Hadizadeh F; Ferreira RJ
J Biomol Struct Dyn; 2021 Aug; 39(13):4752-4763. PubMed ID: 32573349
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells.
Shekari F; Sadeghpour H; Javidnia K; Saso L; Nazari F; Firuzi O; Miri R
Eur J Pharmacol; 2015 Jan; 746():233-44. PubMed ID: 25445037
[TBL] [Abstract][Full Text] [Related]
6. Synthetic Diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylates Induce Apoptosis.
Ahn S; Lee Y; Park J; Lee J; Shin SY; Lee YH; Koh D; Lim Y
Med Chem; 2018; 14(8):851-862. PubMed ID: 29669502
[TBL] [Abstract][Full Text] [Related]
7. Studies on chemoselective synthesis of 1,4- and 1,2-dihydropyridine derivatives by a Hantzsch-like reaction: a combined experimental and DFT study.
Li P; Wang S; Tian N; Yan H; Wang J; Song X
Org Biomol Chem; 2021 May; 19(17):3882-3892. PubMed ID: 33949438
[TBL] [Abstract][Full Text] [Related]
8. Discovery of new symmetrical and asymmetrical nitrile-containing 1,4-dihydropyridine derivatives as dual kinases and P-glycoprotein inhibitors: synthesis,
Saad MH; El-Moselhy TF; S El-Din N; Mehany ABM; Belal A; Abourehab MAS; Tawfik HO; El-Hamamsy MH
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2489-2511. PubMed ID: 36093880
[TBL] [Abstract][Full Text] [Related]
9. Design and Synthesis of 1,4-dihydropyridine Derivatives as Anti-cancer Agent.
Viradiya D; Mirza S; Shaikh F; Kakadiya R; Rathod A; Jain N; Rawal R; Shah A
Anticancer Agents Med Chem; 2017; 17(7):1003-1013. PubMed ID: 27924733
[TBL] [Abstract][Full Text] [Related]
10.
Liu X; Li F; Wen X; Zheng J; Pan W; Li Z
Bioorg Med Chem Lett; 2024 Sep; 109():129818. PubMed ID: 38823726
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of new symmetrical derivatives of dihydropyridine containing a pyridyl group on the 3, 5-positions and evaluation of their cytotoxic and multidrug resistance reversal activity.
Foroughinia F; Javidnia K; Amirghofran Z; Mehdipour A; Miri R
J Pharm Pharmacol; 2008 Nov; 60(11):1481-9. PubMed ID: 18957169
[TBL] [Abstract][Full Text] [Related]
12. Effects of dihydropyridines and pyridines on multidrug resistance mediated by breast cancer resistance protein: in vitro and in vivo studies.
Zhou XF; Yang X; Wang Q; Coburn RA; Morris ME
Drug Metab Dispos; 2005 Aug; 33(8):1220-8. PubMed ID: 15908473
[TBL] [Abstract][Full Text] [Related]
13. Hantzsch reaction: synthesis and characterization of some new 1,4-dihydropyridine derivatives as potent antimicrobial and antioxidant agents.
Vijesh AM; Isloor AM; Peethambar SK; Shivananda KN; Arulmoli T; Isloor NA
Eur J Med Chem; 2011 Nov; 46(11):5591-7. PubMed ID: 21968373
[TBL] [Abstract][Full Text] [Related]
14. b-Annulated 1,4-dihydropyridines as Notch inhibitors.
Gómez-Galeno JE; Hurtado C; Cheng J; Yardimci C; Mercola M; Cashman JR
Bioorg Med Chem Lett; 2018 Nov; 28(20):3363-3367. PubMed ID: 30201292
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents.
Dei S; Coronnello M; Bartolucci G; Manetti D; Romanelli MN; Udomtanakunchai C; Salerno M; Teodori E
Eur J Med Chem; 2018 Mar; 147():7-20. PubMed ID: 29421572
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and 3D-QSAR studies of novel 1,4-dihydropyridines as TGFβ/Smad inhibitors.
Längle D; Marquardt V; Heider E; Vigante B; Duburs G; Luntena I; Flötgen D; Golz C; Strohmann C; Koch O; Schade D
Eur J Med Chem; 2015 May; 95():249-66. PubMed ID: 25817775
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activity of new dihydropyridine thioglycosides and their corresponding dehydrogenated forms.
Abbas HA; El Sayed WA; Fathy NM
Eur J Med Chem; 2010 Mar; 45(3):973-82. PubMed ID: 20004044
[TBL] [Abstract][Full Text] [Related]
18. CoMFA and CoMSIA studies of 1,2-dihydropyridine derivatives as anticancer agents.
Salama I; Abdel-Fattah MA; Hany MS; El-Sharif SA; El-Naggar MA; Rashied RM; Piazza GA; Abadi AH
Med Chem; 2012 May; 8(3):372-83. PubMed ID: 22530888
[TBL] [Abstract][Full Text] [Related]
19. One-pot synthesis of 4,6-diaryl-2-oxo(imino)-1,2-dihydropyridine-3-carbonitrile; a New Scaffold for p38alpha MAP kinase inhibition.
Serry AM; Luik S; Laufer S; Abadi AH
J Comb Chem; 2010 Jul; 12(4):559-65. PubMed ID: 20518551
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of some novel hydrazide, 1,2-dihydropyridine, chromene derivatives carrying biologically active sulfone moieties with potential anticancer activity.
Bashandy MS; Al-Said MS; Al-Qasoumi SI; Ghorab MM
Arzneimittelforschung; 2011; 61(9):521-6. PubMed ID: 22029229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
